Effects of interleukin-12 in the long-term protection conferred by a Mycobacterium avium subunit vaccine

R. A. Silva, T. F. Pais, R. Appelberg

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

The effects of the addition of recombinant interleukin (IL)-12 to a mycobacterial subunit vaccine were analyzed in terms of the longevity of the protective immunity generated. BALB/c mice were immunized with culture filtrate proteins from Mycobacterium avium with dimethyl-dioctadecilammonium bromide (DDA) as an adjuvant. This subunit vaccine induced protection against a challenge by M. avium which lasted for at least 6 months while waning with time until 1 year postvaccination. Whereas the addition of IL-12 enhanced the initial protective efficacy of this subunit vaccine during the first 6 months, it accelerated the loss of protective efficacy observed at 1 year postvaccination. These data confirm the adjuvant properties of IL-12 in vaccines against mycobacteria and raise the possibility of late counter-protective untoward effects.

Original languageEnglish
Pages (from-to)531-533
Number of pages3
JournalScandinavian Journal of Immunology
Volume52
Issue number6
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'Effects of interleukin-12 in the long-term protection conferred by a Mycobacterium avium subunit vaccine'. Together they form a unique fingerprint.

Cite this